Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty, a Prospective, Double Blind, Phase III Study

NCT01229774 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.

NCT NCT01229774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01229774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty, a Prospective, Double Blind, Phase III Study
Lead sponsor
University of Regensburg
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2011
Completion date
August 31, 2014
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasties hip replacement, coxarthrosis, perioperative blood loss